Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 9, Pages 1705
Publisher
MDPI AG
Online
2019-05-02
DOI
10.3390/molecules24091705
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synaptic vesicle protein 2A as a potential biomarker in synaptopathies
- (2019) Kerstin Heurling et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases
- (2018) Zhengxin Cai et al. NEUROSCIENCE LETTERS
- Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates
- (2018) Songye Li et al. ACS Chemical Neuroscience
- Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value
- (2018) Maria Elisa Serrano et al. MOLECULAR IMAGING AND BIOLOGY
- Imaging Synaptic Density: A Different Look at Neurologic Diseases
- (2017) Eugenii A. Rabiner JOURNAL OF NUCLEAR MEDICINE
- Pharmacokinetic Characterization of [18F]UCB-H PET Radiopharmaceutical in the Rat Brain
- (2017) Guillaume Becker et al. MOLECULAR PHARMACEUTICS
- Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease
- (2017) Amy R. Dunn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Puzzling Out Synaptic Vesicle 2 Family Members Functions
- (2017) Odile Bartholome et al. Frontiers in Molecular Neuroscience
- Enabling Efficient Positron Emission Tomography (PET) Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) with a Robust and One-Step Radiosynthesis of a Highly Potent 18F-Labeled Ligand ([18F]UCB-H)
- (2016) Corentin Warnier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
- (2016) N. B. Nabulsi et al. JOURNAL OF NUCLEAR MEDICINE
- [11C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A
- (2016) Sergio Estrada et al. NUCLEAR MEDICINE AND BIOLOGY
- Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's disease
- (2016) Vivian Altmann et al. PHARMACOGENOMICS
- Imaging synaptic density in the living human brain
- (2016) Sjoerd J. Finnema et al. Science Translational Medicine
- Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [18F]UCB-H: First-in-Human Study
- (2015) F. Bretin et al. MOLECULAR IMAGING AND BIOLOGY
- Evaluation of 18F-UCB-H as a Novel PET Tracer for Synaptic Vesicle Protein 2A in the Brain
- (2014) G. I. Warnock et al. JOURNAL OF NUCLEAR MEDICINE
- Radiosynthesis of 11C-Levetiracetam: A Potential Marker for PET Imaging of SV2A Expression
- (2014) Hancheng Cai et al. ACS Medicinal Chemistry Letters
- Expression of SV2 isoforms during rodent brain development
- (2013) Julie Crèvecœur et al. BMC NEUROSCIENCE
- A role for Sv2c in basal ganglia functions
- (2013) D. Dardou et al. BRAIN RESEARCH
- Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H
- (2013) Florian Bretin et al. EJNMMI Research
- Low distribution of synaptic vesicle protein 2A and synaptotagimin-1 in the cerebral cortex and hippocampus of spontaneously epileptic rats exhibiting both tonic convulsion and absence seizure
- (2012) R. Hanaya et al. NEUROSCIENCE
- Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system
- (2010) D. Dardou et al. BRAIN RESEARCH
- Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam
- (2009) Rafal M. Kaminski et al. EPILEPSIA
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
- Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy
- (2008) Erwin A. van Vliet et al. EPILEPSIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started